277 related articles for article (PubMed ID: 6163815)
1. In vitro induction of HLA-restricted cytotoxic T lymphocytes against autologous Epstein-Barr Virus transformed B lymphoblastoid cell line.
Fukukawa T; Hirano T; Sakaguchi N; Teranishi T; Tsuyuguchi I; Nagao N; Naito N; Yoshimura K; Okubo Y; Tohda H; Oikawa A
J Immunol; 1981 May; 126(5):1697-701. PubMed ID: 6163815
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus.
Tanaka Y; Sugamura K; Hinuma Y
J Immunol; 1982 Mar; 128(3):1241-5. PubMed ID: 6173428
[TBL] [Abstract][Full Text] [Related]
3. Memory of Epstein-Barr virus-specific cytotoxic T cells in normal seropostive adults as revealed by an in vitro restimulation method.
Tanaka Y; Sugamura K; Hinuma Y; Sato H; Okochi K
J Immunol; 1980 Oct; 125(4):1426-31. PubMed ID: 6157733
[TBL] [Abstract][Full Text] [Related]
4. Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells.
Kannagi M; Sugamura K; Sato H; Okochi K; Uchino H; Hinuma Y
J Immunol; 1983 Jun; 130(6):2942-6. PubMed ID: 6189906
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2.
Wallace LE; Rowe M; Gaston JS; Rickinson AB; Epstein MA
Eur J Immunol; 1982 Dec; 12(12):1012-8. PubMed ID: 6297919
[TBL] [Abstract][Full Text] [Related]
6. Immune response to alien histocompatibility antigens on Epstein-Barr virus transformed cells.
Mori T; Koishi T; Fujii G; Ohsawa N
Jpn J Exp Med; 1982 Jun; 52(3):125-9. PubMed ID: 6290715
[TBL] [Abstract][Full Text] [Related]
7. Human cytotoxic T lymphocytes. III. Large numbers of peripheral blood T cells clonally develop into allorestricted anti-viral cytotoxic T cell populations in vitro.
Kabelitz D; Herzog WR; Heeg K; Wagner H; Reimann J
J Mol Cell Immunol; 1987; 3(1):49-60. PubMed ID: 2855406
[TBL] [Abstract][Full Text] [Related]
8. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M
Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
[TBL] [Abstract][Full Text] [Related]
9. Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.
Yanagisawa M; Kato M; Ikeno K; Kobayashi T; Miyagawa Y; Komiyama A; Akabane T
Clin Exp Immunol; 1987 May; 68(2):251-8. PubMed ID: 2820633
[TBL] [Abstract][Full Text] [Related]
10. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
Strang G; Rickinson AB
Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
[TBL] [Abstract][Full Text] [Related]
11. Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants.
Plotnicky H; Touraine JL
Clin Exp Immunol; 1993 Dec; 94(3):494-9. PubMed ID: 7504600
[TBL] [Abstract][Full Text] [Related]
12. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies.
van de Griend RJ; Giphart MJ; Van Krimpen BA; Bolhuis RL
J Immunol; 1984 Sep; 133(3):1222-9. PubMed ID: 6205072
[TBL] [Abstract][Full Text] [Related]
13. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
Konttinen YT; Bluestein HG; Zvaifler NJ
J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
[TBL] [Abstract][Full Text] [Related]
15. Cross-killing phenomenon during induction of cytotoxic activity against autologous leukemic cells or autologous Epstein-Barr virus-transformed lymphoblastoid B-cell line.
Maeda Y; Hijikata Y; Yamaguchi T; Morita Y; Kanamaru A
Leuk Res; 2008 Mar; 32(3):510-1. PubMed ID: 17628665
[No Abstract] [Full Text] [Related]
16. Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines.
Meij P; Bloemena E; Palmen N; Brink A; Vervoort MB; Meijer CJ; Middeldorp JM
Cell Immunol; 2001 Feb; 208(1):25-33. PubMed ID: 11277616
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic CD8+ T cells recognize EBV antigen but poorly kill autologous EBV-infected B lymphoblasts: immunodominance is elicited by a peptide epitope that is presented at low levels in vitro.
Shi Y; Smith KD; Kurilla MG; Lutz CT
J Immunol; 1997 Aug; 159(4):1844-52. PubMed ID: 9257848
[TBL] [Abstract][Full Text] [Related]
18. Analysis of cellular immune response to EBV by using cloned T cell lines.
Slovin SF; Schooley RT; Thorley-Lawson DA
J Immunol; 1983 May; 130(5):2127-32. PubMed ID: 6187840
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-induced lymphoblastoid cell lines from seropositive adult donors and their HLA-antigens.
Akiyama N; Ohsawa N; Kusaba R; Inou T; Takada M
Jpn J Exp Med; 1981 Feb; 51(1):1-7. PubMed ID: 6273617
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro.
Moss DJ; Wallace LE; Rickinson AB; Epstein MA
Eur J Immunol; 1981 Sep; 11(9):686-93. PubMed ID: 6170517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
